Detalles de la búsqueda
1.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med
; 387(1): 9-20, 2022 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665782
2.
BRCA1/2 reversion mutations in a pan-cancer cohort.
Cancer Sci
; 115(2): 635-647, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041241
3.
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
Cancer Immunol Immunother
; 73(3): 42, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349455
4.
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
Breast Cancer Res Treat
; 203(2): 225-234, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875670
5.
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
Breast Cancer Res
; 25(1): 13, 2023 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721218
6.
Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry.
Breast Cancer Res Treat
; 201(3): 397-408, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37479943
7.
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial).
Breast Cancer Res Treat
; 199(2): 253-263, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000345
8.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci
; 113(9): 3169-3179, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35754298
9.
Prognosis and effectiveness of chemotherapy for medullary breast carcinoma.
Breast Cancer Res Treat
; 196(3): 635-645, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273358
10.
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).
Jpn J Clin Oncol
; 52(10): 1124-1133, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35750038
11.
The impact of COVID-19 on surgical procedures in Japan: analysis of data from the National Clinical Database.
Surg Today
; 52(1): 22-35, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783905
12.
Current Status of Advance Care Planning and End-of-life Communication for Patients with Advanced and Metastatic Breast Cancer.
Oncologist
; 26(4): e686-e693, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33321004
13.
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.
BMC Cancer
; 21(1): 34, 2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33413212
14.
Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.
Oncologist
; 25(2): e223-e230, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043762
15.
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.
Breast Cancer Res Treat
; 184(2): 585-596, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816191
16.
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study.
Breast Cancer Res Treat
; 178(3): 647-656, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31451979
17.
Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
Ann Surg Oncol
; 26(8): 2475-2485, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102090
18.
[Two Cases of Pneumocystis Pneumonia during Adjuvant Chemotherapy for Breast Cancer].
Gan To Kagaku Ryoho
; 46(12): 1887-1890, 2019 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-31879409
19.
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
Breast Cancer Res
; 25(1): 28, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941639
20.
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.
Breast Cancer Res Treat
; 167(1): 39-47, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28905250